Clinical Trials

NCT04927494 | COMPLETED | NA

288 participants

Cervical Cancer Prevention for Black Adults

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2023-01-01

Completion:

2025-05-10

Conditions

• Cervical Cancer

Interventions

• BEHAVIORAL

Results Available

NCT04912765 | RECRUITING | PHASE2

60 participants

Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-04-15

Completion:

2026-12-31

Conditions

• Hepatocellular Carcinoma
• Hepatocellular Cancer
• Colorectal Cancer
• Colorectal Carcinoma
• Liver Metastases

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT04901195 | ACTIVE_NOT_RECRUITING | PHASE3

658 participants

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-05-27

Completion:

2026-07-28

Conditions

• Hidradenitis Suppurativa

Interventions

• DRUG

No Results Yet

NCT04892173 | RECRUITING | PHASE3

500 participants

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-12-10

Completion:

2028-06-30

Conditions

• Carcinoma, Squamous Cell

Interventions

• DRUG
• RADIATION

No Results Yet

NCT04865172 | COMPLETED

44 participants

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2022-05-20

Completion:

2025-04-18

Conditions

• Frontotemporal Dementia, Behavioral Variant
• Alzheimer Disease

Interventions

• OTHER

No Results Yet

NCT04847453 | ACTIVE_NOT_RECRUITING | PHASE1

24 participants

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2022-08-03

Completion:

2028-06-30

Conditions

• Recurrent AL Amyloidosis
• Refractory AL Amyloidosis

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT04816006 | RECRUITING | NA

160 participants

Breast Cancer, Reasoning, and Activity Intervention

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2024-02-22

Completion:

2028-07-31

Conditions

• Breast Cancer
• Breast Neoplasms
• Anatomic Stage I Breast Cancer AJCC v8
• Anatomic Stage II Breast Cancer AJCC v8
• Anatomic Stage IIIA Breast Cancer AJCC v8
• Cancer-related Cognitive Dysfunction

Interventions

• BEHAVIORAL
• OTHER

No Results Yet

NCT04811560 | RECRUITING | PHASE1/PHASE2

420 participants

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-05-19

Completion:

2027-02-26

Conditions

• Acute Leukemia

Interventions

• DRUG

No Results Yet

NCT04770779 | ACTIVE_NOT_RECRUITING | PHASE3

258 participants

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-11-30

Completion:

2024-04-11

Conditions

• Transfusion-dependent Alpha-Thalassemia
• Transfusion-dependent Beta-Thalassemia

Interventions

• DRUG

Results Available

NCT04770753 | ACTIVE_NOT_RECRUITING | PHASE3

194 participants

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-12-20

Completion:

2023-11-13

Conditions

• Non-Transfusion-dependent Alpha-Thalassemia
• Non-Transfusion-dependent Beta-Thalassemia

Interventions

• DRUG

Results Available

NCT04763681 | COMPLETED | NA

54 participants

Couple HOPES and COVID-19

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-01-01

Completion:

2024-01-31

Conditions

• Posttraumatic Stress Disorder

Interventions

• BEHAVIORAL

No Results Yet

NCT04747249 | COMPLETED | NA

29 participants

Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-06-18

Completion:

2022-03-31

Conditions

• Solid Carcinoma
• Post Traumatic Stress Disorder
• Covid19

Interventions

• OTHER

Results Available

NCT04747054 | RECRUITING | PHASE3

102 participants

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-12-01

Completion:

2026-10-01

Conditions

• Squamous Cell Carcinoma of Head and Neck

Interventions

• DRUG
• RADIATION

No Results Yet

NCT04737239 | COMPLETED

61 participants

Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2020-12-23

Completion:

2026-03-22

Conditions

• Carpal Tunnel Syndrome

Interventions

• OTHER

No Results Yet

NCT04728165 | COMPLETED

27 participants

Anti-Inflammatory Effects of Time-Restricted Feeding

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2021-06-09

Completion:

2023-07-28

Conditions

• Psoriasis
• Systemic Inflammation

No Results Yet

NCT04722146 | ACTIVE_NOT_RECRUITING | PHASE1

140 participants

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-03-12

Completion:

2025-10-03

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT04720625 | COMPLETED | NA

757 participants

Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-06-28

Completion:

2024-10-10

Conditions

• Tobacco Smoking

Interventions

• BEHAVIORAL

Results Available

NCT04691323 | COMPLETED | NA

68 participants

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-03-02

Completion:

2024-06-18

Conditions

• Sickle Cell Disease
• Sickle B+ Thalassemia
• Sickle Beta Zero Thalassemia
• Sickle Cell Hemoglobin C

Interventions

• OTHER

No Results Yet

NCT04688411 | COMPLETED | NA

36 participants

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-09-28

Completion:

2025-09-16

Conditions

• Sickle Cell Disease
• Sickle Beta Zero Thalassemia
• Sickle B+ Thalassemia
• Sickle Cell Hemoglobin C

Interventions

• BEHAVIORAL

No Results Yet

NCT04671667 | RECRUITING | PHASE2

188 participants

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-04-27

Completion:

2029-06-30

Conditions

• Recurrent Head and Neck Squamous Cell Carcinoma
• Recurrent Hypopharyngeal Squamous Cell Carcinoma
• Recurrent Laryngeal Squamous Cell Carcinoma
• Recurrent Oral Cavity Squamous Cell Carcinoma
• Recurrent Oropharyngeal Squamous Cell Carcinoma

Interventions

• DRUG
• PROCEDURE
• RADIATION
• BIOLOGICAL

No Results Yet

NCT04658862 | ACTIVE_NOT_RECRUITING | PHASE3

518 participants

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-12-07

Completion:

2026-12-30

Conditions

• Urinary Bladder Neoplasms

Interventions

• BIOLOGICAL
• DRUG
• RADIATION

No Results Yet

NCT04657289 | ACTIVE_NOT_RECRUITING | PHASE3

451 participants

A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-07-14

Completion:

2027-02-04

Conditions

• Neovascular Age-related Macular Degeneration (nAMD)

Interventions

• DRUG
• DEVICE

No Results Yet

NCT04656652 | ACTIVE_NOT_RECRUITING | PHASE3

605 participants

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-12-21

Completion:

2024-05-10

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT04652960 | ACTIVE_NOT_RECRUITING | PHASE1

38 participants

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-10-21

Completion:

2026-12-03

Conditions

• Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
• Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
• Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT04641442 | ACTIVE_NOT_RECRUITING | PHASE2

17 participants

Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-12-18

Completion:

2025-10-14

Conditions

• NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations

Interventions

• BIOLOGICAL

No Results Yet

NCT04640623 | ACTIVE_NOT_RECRUITING | PHASE2

220 participants

A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-12-18

Completion:

2025-07-03

Conditions

• Urinary Bladder Neoplasms

Interventions

• DRUG
• BIOLOGICAL

Results Available

NCT04631224 | COMPLETED

40 participants

Longitudinal Analysis of Oral Communication in Friedreich's Ataxia

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-31

Start Date:

2015-02-28

Completion:

2016-12-31

Conditions

• Friedreich Ataxia

No Results Yet

NCT04621760 | COMPLETED | NA

189 participants

The OPENS Trial: Offering Women PrEP (Aim 1)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-05-03

Completion:

2022-10-24

Conditions

• Human Immunodeficiency Virus Transmission
• Sexually Transmitted Diseases

Interventions

• BEHAVIORAL

Results Available

NCT04617925 | COMPLETED | PHASE2

35 participants

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-02-26

Completion:

2025-07-17

Conditions

• AL Amyloidosis

Interventions

• DRUG

No Results Yet

NCT04616534 | ACTIVE_NOT_RECRUITING | PHASE1

14 participants

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-06-01

Completion:

2025-04-01

Conditions

• Advanced Fallopian Tube Carcinoma
• Advanced Malignant Solid Neoplasm
• Advanced Ovarian Carcinoma
• Advanced Pancreatic Adenocarcinoma
• Advanced Primary Peritoneal Carcinoma
• Fallopian Tube High Grade Serous Adenocarcinoma
• Metastatic Pancreatic Adenocarcinoma
• Ovarian High Grade Serous Adenocarcinoma
• Platinum-Resistant Fallopian Tube Carcinoma
• Platinum-Resistant Ovarian Carcinoma
• Platinum-Resistant Primary Peritoneal Carcinoma
• Primary Peritoneal High Grade Serous Adenocarcinoma
• Stage II Pancreatic Cancer AJCC v8
• Stage III Fallopian Tube Cancer AJCC v8
• Stage III Ovarian Cancer AJCC v8
• Stage III Pancreatic Cancer AJCC v8
• Stage III Primary Peritoneal Cancer AJCC v8
• Stage IV Fallopian Tube Cancer AJCC v8
• Stage IV Ovarian Cancer AJCC v8
• Stage IV Pancreatic Cancer AJCC v8
• Stage IV Primary Peritoneal Cancer AJCC v8
• Unresectable Pancreatic Adenocarcinoma

Interventions

• PROCEDURE
• DRUG

Results Available

NCT04595747 | ACTIVE_NOT_RECRUITING | PHASE2

48 participants

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-05-03

Completion:

2027-07-31

Conditions

• Locally Advanced Gastrointestinal Stromal Tumor
• Locally Advanced Sarcoma
• Metastatic Gastrointestinal Stromal Tumor
• Metastatic Sarcoma
• Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
• Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8
• Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
• Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT04557098 | ACTIVE_NOT_RECRUITING | PHASE2

194 participants

A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-09-17

Completion:

2021-11-09

Conditions

• Hematological Malignancies

Interventions

• DRUG

No Results Yet

NCT04554914 | ACTIVE_NOT_RECRUITING | PHASE2

190 participants

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-07-14

Completion:

2027-06-30

Conditions

• Epstein-Barr Virus (EBV)-Associated Diseases
• EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)
• EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)
• EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
• EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
• Solid Organ Transplant Complications
• Lymphoproliferative Disorders
• Allogeneic Hematopoietic Cell Transplant
• Stem Cell Transplant Complications
• EBV+ Sarcomas
• Leiomyosarcoma

Interventions

• BIOLOGICAL

No Results Yet

NCT04530565 | ACTIVE_NOT_RECRUITING | PHASE3

348 participants

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-01-25

Completion:

2028-07-01

Conditions

• B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Interventions

• PROCEDURE
• BIOLOGICAL
• DRUG

No Results Yet

NCT04521764 | RECRUITING | PHASE1

54 participants

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-09-23

Completion:

2027-08-15

Conditions

• Anatomic Stage IV Breast Cancer AJCC v8
• Invasive Breast Carcinoma
• Metastatic Breast Adenocarcinoma
• Recurrent Breast Carcinoma
• Stage IV Breast Cancer AJCC v6 and v7

Interventions

• BIOLOGICAL
• PROCEDURE

No Results Yet

NCT04518748 | ACTIVE_NOT_RECRUITING | PHASE1

70 participants

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-09-16

Completion:

2028-05-31

Conditions

• Liver Malignancy

Interventions

• DRUG
• DEVICE
• RADIATION
• DIAGNOSTIC_TEST

No Results Yet

NCT04514497 | ACTIVE_NOT_RECRUITING | PHASE1

29 participants

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-10-20

Completion:

2025-02-15

Conditions

• Metastatic Lung Small Cell Carcinoma
• Metastatic Malignant Solid Neoplasm
• Metastatic Neuroendocrine Carcinoma
• Metastatic Pancreatic Adenocarcinoma
• Stage III Lung Cancer AJCC v8
• Stage III Pancreatic Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8
• Stage IV Pancreatic Cancer AJCC v8
• Unresectable Lung Small Cell Carcinoma
• Unresectable Malignant Solid Neoplasm
• Unresectable Neuroendocrine Carcinoma
• Unresectable Pancreatic Adenocarcinoma

Interventions

• PROCEDURE
• DRUG

Results Available

NCT04491942 | ACTIVE_NOT_RECRUITING | PHASE1

74 participants

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-08-25

Completion:

2027-06-30

Conditions

• Advanced Bile Duct Carcinoma
• Advanced Breast Carcinoma
• Advanced Cervical Carcinoma
• Advanced Endometrial Carcinoma
• Advanced Esophageal Carcinoma
• Advanced Gastric Carcinoma
• Advanced Head and Neck Carcinoma
• Advanced Lung Non-Small Cell Carcinoma
• Advanced Lung Small Cell Carcinoma
• Advanced Malignant Solid Neoplasm
• Advanced Ovarian Carcinoma
• Advanced Penile Carcinoma
• Advanced Pleural Malignant Mesothelioma
• Advanced Urothelial Carcinoma
• Anatomic Stage III Breast Cancer AJCC v8
• Anatomic Stage IV Breast Cancer AJCC v8
• Clinical Stage III Gastric Cancer AJCC v8
• Clinical Stage IV Gastric Cancer AJCC v8
• Stage III Cervical Cancer AJCC v8
• Stage III Distal Bile Duct Cancer AJCC v8
• Stage III Intrahepatic Bile Duct Cancer AJCC v8
• Stage III Lung Cancer AJCC v8
• Stage III Ovarian Cancer AJCC v8
• Stage III Penile Cancer AJCC v8
• Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8
• Stage IV Cervical Cancer AJCC v8
• Stage IV Distal Bile Duct Cancer AJCC v8
• Stage IV Intrahepatic Bile Duct Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8
• Stage IV Ovarian Cancer AJCC v8
• Stage IV Penile Cancer AJCC v8
• Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v8
• Triple-Negative Breast Carcinoma
• Unresectable Urothelial Carcinoma

Interventions

• DRUG

No Results Yet

NCT04460937 | ACTIVE_NOT_RECRUITING | PHASE1

4 participants

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2021-04-09

Completion:

2024-03-29

Conditions

• Clinical Stage III Esophageal Adenocarcinoma AJCC v8
• Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Distal Esophagus Adenocarcinoma
• Gastric Cardia Adenocarcinoma
• Metastatic Esophageal Adenocarcinoma
• Metastatic Esophageal Squamous Cell Carcinoma
• Metastatic Gastroesophageal Junction Adenocarcinoma
• Metastatic Malignant Neoplasm in the Brain
• Metastatic Malignant Neoplasm in the Leptomeninges
• Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
• Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Unresectable Esophageal Adenocarcinoma
• Unresectable Esophageal Carcinoma
• Unresectable Esophageal Squamous Cell Carcinoma
• Unresectable Gastroesophageal Junction Adenocarcinoma

Interventions

• DRUG
• RADIATION

Results Available

NCT04458922 | ACTIVE_NOT_RECRUITING | PHASE2

27 participants

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-31

Start Date:

2020-10-05

Completion:

2022-11-28

Conditions

• Central Chondrosarcoma, Grade 2
• Central Chondrosarcoma, Grade 3
• Dedifferentiated Chondrosarcoma
• Metastatic Clear Cell Sarcoma of Soft Tissue
• Metastatic Primary Central Chondrosarcoma
• Unresectable Primary Central Chondrosarcoma

Interventions

• DRUG
• PROCEDURE

Results Available